These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7211088)

  • 21. Effects of mild hyperinsulinemia on the metabolic response to exercise.
    Martin MJ; Horwitz DL; Nattrass M; Granger JF; Rochman H; Ash S
    Metabolism; 1981 Jul; 30(7):688-94. PubMed ID: 7017343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of hormonal and metabolic effects of salbutamol infusion in normal subjects and insulin-requiring diabetics.
    Gündogdu AS; Brown PM; Juul S; Sachs L; Sönksen PH
    Lancet; 1979 Dec 22-29; 2(8156-8157):1317-21. PubMed ID: 92670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketogenic action of glucagon in insulin-dependent diabetic subjects.
    Harano Y; Ohgaku S; Shimizu Y; Izumi K; Takahashi J
    Endocrinol Jpn; 1977 Apr; 24(2):121-8. PubMed ID: 406133
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic man.
    Schade DS; Eaton RP
    Horm Metab Res; 1977 Jul; 9(4):253-7. PubMed ID: 892688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent metabolic abnormalities in diabetes in the absence of glucagon.
    Barnes AJ; Bloom SR; Mashiter K; Alberti KG; Smythe P; Turnell D
    Diabetologia; 1977 Jan; 13(1):71-5. PubMed ID: 838205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control.
    Krzentowski G; Scheen A; Castillo M; Luyckx AS; Lefèbvre PJ
    Diabetologia; 1983 May; 24(5):314-8. PubMed ID: 6347779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Laager R; Keller U
    Diabetologia; 1993 Oct; 36(10):966-71. PubMed ID: 8243878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some metabolic and hormonal effects of salbutamol in man.
    Massara F; Fassio V; Camanni F; Martina V; Molinatti G
    Acta Diabetol Lat; 1976; 13(3-4):146-53. PubMed ID: 1020612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of cortisol to glucose counterregulation in humans.
    De Feo P; Perriello G; Torlone E; Ventura MM; Fanelli C; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    Am J Physiol; 1989 Jul; 257(1 Pt 1):E35-42. PubMed ID: 2665516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic effects of oral salbutamol in late pregnancy.
    Lunell NO; Wager J; Fredholm BB; Persson B
    Eur J Clin Pharmacol; 1978 Nov; 14(2):95-9. PubMed ID: 214306
    [No Abstract]   [Full Text] [Related]  

  • 32. Dose-response studies on the metabolic effects of a growth hormone pulse in humans.
    Møller N; Schmitz O; Pørksen N; Møller J; Jørgensen JO
    Metabolism; 1992 Feb; 41(2):172-5. PubMed ID: 1736039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence against important catecholamine compensation for absent glucagon counterregulation.
    De Feo P; Perriello G; Torlone E; Fanelli C; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E203-12. PubMed ID: 1996624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
    Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
    Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon.
    Staten MA; Matthews DE; Cryer PE; Bier DM
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discrepant effect of the prostaglandin synthesis inhibitor acetylsalicylic acid on insulin and C-peptide response to glucose in man.
    Ratzmann KP; Besch W; Witt S; Schulz B
    Horm Metab Res; 1982 Oct; 14(10):508-12. PubMed ID: 6757082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic glucose production during intraperitoneal and intravenous closed-loop insulin regulation of blood glucose in type 1 (insulin-dependent) diabetic patients.
    Robert JJ; Chauvet D; Darmaun D; Leblanc H
    Diabetologia; 1993 Nov; 36(11):1185-90. PubMed ID: 8270134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects.
    Prince RL; Larkins RG; Alford FP
    Metabolism; 1981 Mar; 30(3):293-8. PubMed ID: 7010074
    [No Abstract]   [Full Text] [Related]  

  • 39. Absence of exercise-induced hypoglycaemia in type i (insulin-dependent) diabetic patients during maintenance of normoglycaemia by short-term, open-loop insulin infusion.
    Martin MJ; Robbins DC; Bergenstal R; LaGrange B; Rubenstein AH
    Diabetologia; 1982 Oct; 23(4):336-42. PubMed ID: 6754517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma glucagon and alanine responses to acute insulin deficiency in man.
    Gerich JE; Tsalikian E; Lorenzi M; Karam JH; Bier DM
    J Clin Endocrinol Metab; 1975 Mar; 40(3):526-9. PubMed ID: 1117061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.